Literature DB >> 22197977

Mice completely lacking immunoproteasomes show major changes in antigen presentation.

Eleanor Z Kincaid1, Jenny W Che, Ian York, Hernando Escobar, Eduardo Reyes-Vargas, Julio C Delgado, Raymond M Welsh, Margaret L Karow, Andrew J Murphy, David M Valenzuela, George D Yancopoulos, Kenneth L Rock.   

Abstract

The importance of immunoproteasomes to antigen presentation has been unclear because animals totally lacking immunoproteasomes had not been available. Having now developed mice lacking the three immunoproteasome catalytic subunits, we found that the dendritic cells of these mice had defects in presenting several major histocompatibility complex (MHC) class I epitopes. During viral infection in vivo, the presentation of a majority of MHC class I epitopes was markedly reduced in immunoproteasome-deficient animals compared with wild-type animals, whereas presentation of MHC class II peptides was unaffected. According to mass spectrometry, the repertoire of MHC class I-presented peptides was ∼50% different from that in wild-type mice, and these differences were sufficient to stimulate robust transplant rejection of wild-type cells in mutant mice. These results indicated that immunoproteasomes were more important in antigen presentation than previously thought.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197977      PMCID: PMC3262888          DOI: 10.1038/ni.2203

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  42 in total

1.  Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation.

Authors:  A Macagno; L Kuehn; R de Giuli; M Groettrup
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

2.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.

Authors:  Michael A Brehm; Amelia K Pinto; Keith A Daniels; Jonathan P Schneck; Raymond M Welsh; Liisa K Selin
Journal:  Nat Immunol       Date:  2002-06-03       Impact factor: 25.606

3.  Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.

Authors:  Michael Basler; Nikolay Youhnovski; Maries Van Den Broek; Michael Przybylski; Marcus Groettrup
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

4.  Expression of housekeeping and immunoproteasome subunit genes is differentially regulated in positively and negatively selecting thymic stroma subsets.

Authors:  Ahmed Nil; Elke Firat; Vera Sobek; Klaus Eichmann; Gabriele Niedermann
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

5.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

Review 6.  Accessory proteins that control the assembly of MHC molecules with peptides.

Authors:  L Van Kaer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  Antibody-complement interactions with purified lymphocytic choriomeningitis virus.

Authors:  R M Welsh; P W Lampert; P A Burner; M B Oldstone
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

8.  The preparation and characterization of anti-peptide heteroantisera recognizing subregions of the intracytoplasmic domain of class I H-2 antigens.

Authors:  M H Smith; J M Parker; R S Hodges; B H Barber
Journal:  Mol Immunol       Date:  1986-10       Impact factor: 4.407

9.  xIAP induces cell-cycle arrest and activates nuclear factor-kappaB : new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells.

Authors:  B Levkau; K J Garton; N Ferri; K Kloke; J R Nofer; H A Baba; E W Raines; G Breithardt
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

10.  Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

Authors:  W Chen; C C Norbury; Y Cho; J W Yewdell; J R Bennink
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  111 in total

1.  Immuno-waste exposure and further management.

Authors:  Robbert M Spaapen; Jacques Neefjes
Journal:  Nat Immunol       Date:  2012-01-19       Impact factor: 25.606

Review 2.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I.

Authors:  Jeff D Colbert; Diego J Farfán-Arribas; Kenneth L Rock
Journal:  J Immunol       Date:  2013-10-30       Impact factor: 5.422

4.  Lifespan of mice and primates correlates with immunoproteasome expression.

Authors:  Andrew M Pickering; Marcus Lehr; Richard A Miller
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

5.  Proteolytic dynamics of human 20S thymoproteasome.

Authors:  Ulrike Kuckelkorn; Sabine Stübler; Kathrin Textoris-Taube; Christiane Kilian; Agathe Niewienda; Petra Henklein; Katharina Janek; Michael P H Stumpf; Michele Mishto; Juliane Liepe
Journal:  J Biol Chem       Date:  2019-03-26       Impact factor: 5.157

Review 6.  Census of cytosolic aminopeptidase activity reveals two novel cytosolic aminopeptidases.

Authors:  Nadja Akkad; Mark Schatz; Jörn Dengjel; Stefan Tenzer; Hansjörg Schild
Journal:  Med Microbiol Immunol       Date:  2012-09-14       Impact factor: 3.402

7.  Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.

Authors:  Diego J Farfán-Arribas; Lawrence J Stern; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

Review 8.  Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.

Authors:  Masanori Kasahara; Martin F Flajnik
Journal:  Immunogenetics       Date:  2019-01-24       Impact factor: 2.846

9.  Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.

Authors:  Pradeep K Singh; Hao Fan; Xiuju Jiang; Lei Shi; Carl F Nathan; Gang Lin
Journal:  ChemMedChem       Date:  2016-08-25       Impact factor: 3.466

10.  Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.

Authors:  Mary K McCarthy; Danielle H Malitz; Caitlyn T Molloy; Megan C Procario; Kaitlyn E Greiner; Luna Zhang; Ping Wang; Sharlene M Day; Saul R Powell; Jason B Weinberg
Journal:  Virology       Date:  2016-08-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.